Given its effectiveness, its no surprise that prescriptions for Ozempic have increased by 857% since 2019
The Peptide Innovation for Early Diabetes Treatment (PIONEER) programme consisted of eight phase 3, randomized, controlled clinical studies and showed that oral semaglutide reduces glycated haemoglobin (HbA1c) and body weight in patients with T2DM and has potential cardiovascular benefits [35,36,37,38,39,40,41,42]
Front Pharmacol 15:1347047 Nabrdalik K, Skonieczna-ydecka K, Irlik K, Hendel M, Kwiendacz H, oniewski I, Lip GY (2022) Gastrointestinal adverse events of Metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials
Potential mechanisms include weight loss, suppression of cholecystokinin secretion and reduced gallbladder emptying. Reference: He L, et al